Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Philip Morris International Inc. (NYSE:PM) securities between July 26, 2016 and December 20, 2017 (the "Class Period"). Investors have until February 20, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that there were irregularities in the clinical experiments that underpin Philip Morris' FDA application for approval of its iQOS smoking device. Consequently, Defendants' statements about Philip Morris' business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis throughout the Class Period.

On December 20, 2017, Reuters reported that former Philip Morris employees and contractors "detailed irregularities in the clinical experiments that underpin Philip Morris International's application to the FDA for approval of its iQOS smoking device." The report further stated that Tamara Koval, who helped coordinate clinical trials for the device, was "excluded from meetings" after she "questioned the quality of some of the researchers and sites contracted to carry out those experiments."

Following this news, Philip Morris shares fell $3.75 per share, or nearly 3.5%, to close at $104.37 on December 20, 2017.

If you purchased or otherwise acquired Philip Morris securities and suffered a loss, continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the Philip Morris lawsuit, please go to For additional information about Bragar Eagel & Squire, P.C., please go to

View source version on

Copyright Business Wire 2010